RE:Progresson-target, what you posted is old news but what you posted is valuable. It shows that wallyworld doesn’t pay any attention to anyone’s written words but solely relies on the selfie shooting halfwit to tell him what he wants to hear. He’s not capable of much else, otherwise he wouldn’t post like Gerald McBoing Boing. For clarification, somewhat, that source for wallyworld would be the company’s overpaid paperweight.
As as I understand it, enrolment is a POTENTIAL trial subject who has signed on some dotted line. When it comes to this enrolee they must eat some sort of meal and then have blood measured to check for c-Peptide markers in the blood. They must NOT show any signs of some form of positive c-Peptide markers (***Anyone, please correct me if I don’t have this correct) from the pancreas, in whole or in part; hence the term “hypoglycaemic unawareness”. If, initially, there are no signs of c-Peptide then they are good to go for trials and will be implanted with the pouch for openers. So, to clarify and again, as I understand it, they may be enrolled but not necessarily implanted with the cell pouch and the subsequent dosage of pancreatic islets as per the FDA Trial criteria. It’s also my understanding that hypoglycaemic unawareness is the worst possible scenario for anyone stricken with this catastrophic disease. Going back, the July 3rd news was monumental in that sense in that it showed that the cell pouch and the islet dosage in that particular trial subject was working to the degree that the islets were thriving right along and acting as they should within the cell pouch in that they showed the presence of c-Peptide.
So, for all of that, as positive as it may appear......We Wait!!!